Thomas Lee Sutton

20PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?

Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson

|Mar 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?

Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph

|Sep 08, 2023
Targeting the RNA-Binding Protein HuR in Cancer.

Jennifer M Finan, Thomas L Sutton, Dan A Dixon

|Apr 25, 2023
Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer.

Shay Behrens, Thomas L Sutton, Ranish Patel

Pageof 4